celastrol has been researched along with nsc-87877 in 1 studies
| Studies (celastrol) | Trials (celastrol) | Recent Studies (post-2010) (celastrol) | Studies (nsc-87877) | Trials (nsc-87877) | Recent Studies (post-2010) (nsc-87877) |
|---|---|---|---|---|---|
| 885 | 1 | 741 | 40 | 0 | 30 |
| Protein | Taxonomy | celastrol (IC50) | nsc-87877 (IC50) |
|---|---|---|---|
| Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) | 0.36 | |
| Tyrosine-protein phosphatase non-receptor type 11 | Homo sapiens (human) | 0.319 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Song, Y; Wang, S; Yang, X; Yu, B; Zhao, M | 1 |
1 review(s) available for celastrol and nsc-87877
| Article | Year |
|---|---|
Strategies Targeting Protein Tyrosine Phosphatase SHP2 for Cancer Therapy.
Topics: Animals; Antineoplastic Agents; Drug Design; Drug Discovery; Enzyme Inhibitors; Humans; Neoplasms; Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2022 |